NFKB1 and glioblastoma: This is a proteasome inhibitor, it has been reported that induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction and activation of p38-JNK1/2 signaling [42].